Medications
Lawsuit disputes claims of popular memory loss supplement
A government lawsuit seeks to ban a popular memory loss dietary supplement marketed to seniors, saying there's no scientific evidence to support its claims.
Jan 9, 2017
0
1
Page 6 - News tagged with federal trade commission
Health
Study about branded drug website risk disclosure gets FTC attention
Do you take time to read the risk warnings on drug websites before you take the drug?
Oct 12, 2016
0
0
Medications
New York state opens antitrust probe of Mylan's EpiPen
New York state has launched an antitrust probe into Mylan's sale of the EpiPen anti-allergy injector to local school systems, New York's attorney general announced Tuesday.
Sep 6, 2016
0
3
Medications
Mylan launching cheaper, generic version of EpiPen
The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues—and looming competition threatens its near-monopoly.
Aug 29, 2016
0
0
Other
Teva expect to close $40.5B Allergan generic deal next week
Israeli drugmaker Teva, the largest generic drug company in the world, said Wednesday it expects to complete its $40.5 billion purchase of the generic drug business of competitor Allergan next week after federal regulators ...
Jul 27, 2016
0
5
Neuroscience
The resilience of brain-training hype
It was definitely déjà vu in the media today. Reuters, The New Yorker, Los Angeles Times, and more were back on the "brain training prevents dementia" bandwagon.
Jul 26, 2016
0
14
Psychology & Psychiatry
Financial fraud targeting older adults often involves appeals to emotions like anger, excitement
An appeal to emotions like excitement or anger is a key persuasion tactic used by fraudsters to mislead the elderly.
May 4, 2016
0
5
Health
Survey examines Americans' use of and satisfaction with homeopathic medicines
A new survey finds that homeopathic medicines are primarily used by a small segment of the U.S. population for common, self-limited conditions such as the common cold or back pain. The report published in the American Journal ...
Feb 18, 2016
0
11
Other
Universal Health Services buying Foundations for $350M
Universal Health Services, one of the largest hospital operators in the U.S., said Friday it will buy addiction treatment facility company Foundations Recovery Network for $350 million.
Sep 18, 2015
0
6
Medications
Pfizer says Hospira purchase will close in early September
Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September.
Aug 24, 2015
0
10
